GSK

Value Q4, 25 Current Total common shares outstanding 2.16 B 2.16 B Enterprise value 105.81 B 107.49 B Price to earnings ratio — — Price to sales ratio — — Price to cash flow ratio — — Price to book ratio — — Enterprise value to EBITDA ratio — — Return on assets % — — Return on equity % — — Return on invested capital % — — Gross margin % — — Operating margin % — — EBITDA margin % — — Net margin % — — Quick ratio — — Current ratio — — Inventory turnover — — Asset turnover — — Debt to assets ratio — — Debt to equity ratio — — Long term debt to total assets ratio — — Long term debt to total equity ratio — — Operating cash flow per share — — EBIT per share — — EBITDA per share — — Total debt per share — — Cash per share — — Net current asset value per share — — Tangible book value per share — — Working capital per share — — Book value per share — —